23andMe launches new genetic report on osteoporosis
Holding released a new polygenic risk score report on the genetics of osteoporosis for 23andMe+ Premium members. The report ...
23andMe considers sale as cash runs low
The genetic testing company ended last year with $79.4 million and told investors it will need to raise money to fund its ...
23andMe might sell itself as it runs out of money
Me (ME), the company that popularized consumer genetic testing, announced Tuesday that it is once again exploring “strategic ...
23andMe has been quietly exploring a possible sale of its telehealth business, Lemonaid
The struggling genetic-testing 23andMe is looking for a buyer for the virtual-care business it acquired in 2021, Business ...
Nature8d
What went wrong at 23andMe? Why the genetic-data giant risks collapse
At-home DNA testing is no longer in high demand — and critics have raised concerns about unreliable tests and privacy.
pharmaphorum2d
Troubled 23andMe is exploring a sale of the business
Shares in 23andMe are currently trading at around $3.40, giving it a valuation of just under $82 million. The company went ...
23andMe Sags on New Report
Me Holding Co. (NASDAQ: ME), a leading human genetics company with a mission to help people access, understand, and benefit from the human genome, today released a new polygenic risk score (PRS) ...
24 Shocking, Dark, And Wild DNA Test Stories From Things Like 23andMe
They did 23andMe a few years after my siblings and I did. One cousin showed up as a half-sibling, one showed up as a ...
24 Shocking, Dark, And D-R-A-M-A-T-I-C Stories People Shared From Taking DNA Tests
1."My Dad is an identical twin. So, all three of my uncle's children should be my half-siblings genetically. They did 23andMe ...